OLD Category: Oncology

Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures

• Wong WJ et al.,

Host Genome Variation is Associated with Neurocognitive Outcome in Survivors of Pediatric Medulloblastoma

• Siegel BI et al.,

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma

• Zhang L et al.,

Genomic landscape of tumor-host interactions with differential prognostic and predictive connotations

• Roelands J et al.,

Next-generation characterization of the Cancer Cell Line Encyclopedia

• Ghandi M et al.

Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response

• Baeuerle PA et al.,

The immune microenvironment in hormone receptor-positive breast cancer before and after preoperative chemotherapy

• Waks AG et al.,

Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy

• Vázquez-Arreguín K et al.,

Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy

• Klanova M et al.,

Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis

• Allen CT et al.,

A multigene assay determines risk of recurrence in patients with triple-negative breast cancer

• Stewart RL et al.,

Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma

• Boldrini L et al.,